Segall Bryant & Hamill, LLC
- SEC CIK
- 0001006378
- Latest filing
- Aug 12, 2026
BPMC holding history
Blueprint Medicines Corp in every 13F filed by Segall Bryant & Hamill, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BPMC overviewAll 13F holders of BPMCFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 17
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −135,909−100.0% | Sold out | Holders |
| Q1 2025 | 135,909 | $12.0M | 0.2% | −3,834−2.7% | Reduced | Holders |
| Q4 2024 | 139,743 | $12.2M | 0.2% | −1,879−1.3% | Reduced | Holders |
| Q3 2024 | 141,622 | $13.1M | 0.2% | +14,668+11.6% | Added | Holders |
| Q2 2024 | 126,954 | $13.7M | 0.2% | +3,457+2.8% | Added | Holders |
| Q1 2024 | 123,497 | $11.7M | 0.2% | −1,752−1.4% | Reduced | Holders |
| Q4 2023 | 125,249 | $11.6M | 0.2% | +30,099+31.6% | Added | Holders |
| Q3 2023 | 95,150 | $4.78M | 0.1% | −561−0.6% | Reduced | Holders |
| Q2 2023 | 95,711 | $6.05M | 0.1% | +531+0.6% | Added | Holders |
| Q1 2023 | 95,180 | $4.28M | <0.1% | −87,480−47.9% | Reduced | Holders |
| Q4 2022 | 182,660 | $8.00M | 0.1% | −25,971−12.4% | Reduced | Holders |
| Q3 2022 | 208,631 | $13.7M | 0.2% | +4,443+2.2% | Added | Holders |
| Q2 2022 | 204,188 | $10.3M | 0.1% | +28,752+16.4% | Added | Holders |
| Q1 2022 | 175,436 | $11.2M | 0.1% | +116,602+198.2% | Added | Holders |
| Q4 2021 | 58,834 | $6.30M | 0.1% | +15,498+35.8% | Added | Holders |
| Q3 2021 | 43,336 | $4.45M | <0.1% | +1,146+2.7% | Added | Holders |
| Q2 2021 | 42,190 | $3.71M | <0.1% | +2,557+6.5% | Added | Holders |
| Q1 2021 | 39,633 | $3.85M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.